Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FNS1W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,634
Award facts
- Contract value 100% obligated
- $14,634.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,634.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Zepbound 10 mg/0.5 ml pens. This competitively awarded, non-set-aside contract has an ultimate completion date of January 23, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Zepbound (tirzepatide) is a pharmaceutical product used for chronic weight management. The delivery order is executed under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031.
This delivery order represents a routine pharmaceutical supply transaction within the broader DLA Troop Support Medical pharmaceutical prime vendor program, which ensures a consistent supply of medications and medical supplies to military treatment facilities and veteran healthcare systems worldwide. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills such orders across multiple therapeutic domains. The competitively awarded structure and firm fixed-price model demonstrate the company's established capability to meet federal procurement requirements for critical medical commodities supporting the Defense Health Agency and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DR26FNS1W?
SPE2DR26FNS1W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FNS1W worth?
The government has obligated $14,634 on SPE2DR26FNS1W.
Is contract SPE2DR26FNS1W an order under another contract?
Yes. SPE2DR26FNS1W is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNS1W competed?
The extent of competition for SPE2DR26FNS1W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award